Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis
Journal article
Sasson SC. et al, (2021), Gastroenterology, 161, 1229 - 1244.e9
Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis.
Journal article
Walsh A. et al, (2019), Intestinal research, 17, 365 - 374
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis
Journal article
Walsh A. et al, (2019), Journal of Crohn's and Colitis, 13, 424 - 430
Immunotherapy-related hepatitis: Real-world experience from a tertiary centre
Journal article
Cheung V. et al, (2019), Frontline Gastroenterology
Can patients enter the 'Standard Set' ICHOM parameters by completing electronic questionnaires?
Conference paper
Walsh A. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S140 - S141
Could an escalation of therapy or intervention (ETI) calculator be used to triage appointments for patients with ulcerative colitis?
Conference paper
Walsh A. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S397 - S398
Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres
Conference paper
Cheung V. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S137 - S138
Anorexia, vomiting and weight loss in a 22-year-old woman.
Journal article
Cheung VTF. et al, (2018), Gut
INCIDENCE AND MANAGEMENT OF IMMUNOTHERAPY-INDUCED COLITIS IN A TERTIARY IBD CENTRE - CLINICAL PRACTICE DATA
Conference paper
Gupta T. et al, (2018), GUT, 67, A186 - A187
DEVELOPING AN INDEX THAT PREDICTS ESCALATION OF THERAPY AT AN OUTPATIENT APPOINTMENT IN PATIENTS WITH KNOWN ULCERATIVE COLITIS (UC)
Conference paper
Walsh A. et al, (2018), GASTROENTEROLOGY, 154, S587 - S587
NEW FAECAL CALPROTECTIN CUT-OFF POINTS FOR REMISSION AND ACTIVE DISEASE DEFINED BY UCEIS AND NANCY INDICES IN ULCERATIVE COLITIS
Conference paper
Walsh A. et al, (2018), GASTROENTEROLOGY, 154, S187 - S187
Can daily SCCAI measurements over a 6-month period better phenotype the pattern of disease in ulcerative colitis?
Conference paper
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S359 - S360
Development of an index that predicts escalation of therapy at an outpatient appointment in patients with known ulcerative colitis (UC)
Conference paper
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S321 - S321
Fertility and reproduction in a tertiary IBD centre: the Oxford experience
Conference paper
Lee LH. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S173 - S173
Incidence and management of immunotherapy-induced colitis in a tertiary melanoma and IBD centre: Clinical practice data
Conference paper
Cheung V. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S198 - S198
New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)
Conference paper
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S233 - S233
Should extraintestinal manifestations (EIMs) be part of disease activity assessment in ulcerative colitis?
Conference paper
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S461 - S461
The impact of a virtual clinic on clinical decision-making and healthcare resource use vs. standard care: The Oxford experience
Conference paper
FitzPatrick M. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S393 - S394
TrueColours ulcerative colitis (TCUC): Will patients with UC complete digital questionnaires in real-time?
Conference paper
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S286 - S286